bibliographic resource 4338650 [br/4338650]
https://w3id.org/oc/corpus/br/4338650

is a

• document
• article

title

• Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)

publication date

• 2015-01-01

contributor

• https://w3id.org/oc/corpus/ar/16613277
• https://w3id.org/oc/corpus/ar/16613278
• https://w3id.org/oc/corpus/ar/16613279
• https://w3id.org/oc/corpus/ar/16613280
• https://w3id.org/oc/corpus/ar/16613281
• https://w3id.org/oc/corpus/ar/16613282
• https://w3id.org/oc/corpus/ar/16613283
• https://w3id.org/oc/corpus/ar/16613284
• https://w3id.org/oc/corpus/ar/16613285
• https://w3id.org/oc/corpus/ar/16613286
• https://w3id.org/oc/corpus/ar/16613287
• https://w3id.org/oc/corpus/ar/16613288
• https://w3id.org/oc/corpus/ar/16613289
• https://w3id.org/oc/corpus/ar/16613290
• https://w3id.org/oc/corpus/ar/16613291

format

• https://w3id.org/oc/corpus/re/2448134

identifier

• https://w3id.org/oc/corpus/id/8674540
• https://w3id.org/oc/corpus/id/8674541
• https://w3id.org/oc/corpus/id/8674542

part of

• https://w3id.org/oc/corpus/br/69186